Cargando…
Drugs under preclinical and clinical study for treatment of acute and chronic lymphoblastic leukemia
Targeted therapy has modernized the treatment of both chronic and acute lymphoblastic leukemia. The introduction of monoclonal antibodies and combinational drugs has increased the survival rate of patients. Preclinical studies with various agents have resulted in positive outputs with Phase III tria...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920255/ https://www.ncbi.nlm.nih.gov/pubmed/27382259 http://dx.doi.org/10.2147/PPA.S109477 |